Kanada - angličtina - Health Canada

talecris biotherapeutics inc - immunoglobulin (human) - solution - 10g - immunoglobulin (human) 10g - serums

Kanada - angličtina - Health Canada

grifols therapeutics llc - immunoglobulin (human) - solution - 10g - immunoglobulin (human) 10g - serums

Kanada - angličtina - Health Canada

grifols therapeutics llc - immunoglobulin (human) - solution - 10g - immunoglobulin (human) 10g - serums

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - garlic oil, quantity: 1 mg (equivalent: garlic oil, qty 3 g) - capsule, soft - excipient ingredients: gelatin; glycerol; vanillin; purified water; soya oil; peppermint oil - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; traditionally used in western herbal medicine to relieve feelings of general malaise/general debility ; maintain/support general health and wellbeing ; traditionally used in western herbal medicine to antispasmodic/spasmolytic ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of common colds and flu (linked indication:relieve feelings of general malaise/general debility; decrease/reduce/relieve sneezing; decrease/reduce/relieve cough; relieve runny/dripping nose); traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of common colds and flu ; traditionally used in western herbal medicine to decrease/reduce excess mucous ; traditionally used in western herbal medicine to decrease/reduce/relieve mild upper respiratory tract congestion ; traditionally used in western herbal medicine to expectorant/clear respiratory tract mucous ; traditionally used in western herbal medicine to decrease/reduce/relieve sneezing ; traditionally used in western herbal medicine to relieve symptoms of mild upper respiratory tract infections ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of common cold ; traditionally used in western herbal medicine to decrease/reduce/relieve cough ; traditionally used in western herbal medicine to relieve runny/dripping nose

Austrália - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

peerless emulsion products pty ltd - phenothrin-d | tetramethrin - household insecticide - domestic pest control | garden shed | homestead | houses | outbuildings - fly | mosquito | adult mosquitoes

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

wiselink group pty ltd - 56286 - nitrile examination/treatment glove, non-powdered - the powerless nitrile gloves intended as a protective barrier when worn on the hands of healthcare providers during patient examination/treatment or for other sanitary purposes. the device is used mainly as a two-way barrier to protect patient/staff against contaminants and risk of allergy to latex. this is a single-use device.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; propylene glycol; propylene glycol monostearate; white beeswax - for the relief of the inflammatory and pruritic manifestations of resistant or severe corticosteroid responsive dermatoses. these include atopic eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus and psoriasis. diprosone ov ointment is also indicated for the maintenance of remission in chronic psoriasis.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; hypromellose - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; maltodextrin; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: stearic acid; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.